Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jul 5;22(9):1520–1528. doi: 10.1158/1055-9965.EPI-13-0345

Table 2.

Results for single nucleotide variantsa identified by whole-exome sequencing and genotyped in 270 independent HPC families of European ancestry

Discovery Validation

Gene Genomic Position (hg19) Variant and rs ID Protein MAF in ESP MAF in ClinSeq No. of WES families with carriers (Aff/Unaff)b No. (%) of 270 families with affected carriers MAF in 819 genotyped affected menc MAF in 496 genotyped unaffected menc P-valued
BTNL2 Chr6: 32,363,888 C>T rs41441651 Missense: p.Asp336Asn 0.009 0.005 2 (10/0) 9 (3.33) 0.0073 0 0.0032
BTNL2 Chr6: 32,362,521 C>A rs28362675 Missense: p.Gly454Cys 0.008 0.005 2 (10/0) 8 (2.96) 0.0061 0 0.0070
a

Top ranked (P < 0.05) single nucleotide variants identified by whole-exome sequencing (WES) of 19 HPC families.

b

Aff = number of affected carriers / Unaff = number of unaffected carriers.

c

The number of affected carriers for rs41441651 and rs28362675 is 12 and 10, respectively, in the 270 independent HPC families.

d

Monte-Carlo based one-sided P-value from the PedGenie chi-square test for association based on the 270 independent HPC families.